Nvidia announced that it would build Britain’s most powerful supercomputer. The company will invest around $52m on the “Cambridge-1” supercomputer, which will comprise of 80 Nvidia systems and focus on AI research in health and medical care, including COVID-19 challenges. It's expected to come online this year.
- Nvidia founder and CEO Jensen Huang revealed the plans at the company’s GTC 2020 conference on Monday. He said that addressing the greatest challenges in healthcare "requires massively powerful computing resources to harness the capabilities of AI."
- Cambridge-1 would rank as the U.K.'s most powerful supercomputer and the world’s 29th most powerful, as well as among the top three most energy-efficient supercomputers worldwide. It will be built on the Nvidia DGX SuperPOD system, capable of processing 400 petaflops of AI performance and 8 petaflops of Linpack performance.
- Pharma companies GlaxoSmithKline and AstraZeneca and King’s College London are among those that have registered to use the supercomputer.
- It's the second Nvidia supercomputer in the U.K. The first is currently under development at Nvidia's research center in Cambridge, England.
- Cambridge-1 will also be based in the U.K. city, which is where Arm's headquarters are. Nvidia said last month it plans to acquire Arm for up to $40b. Cambridge-1 will be independent of Arm.
More Nvidia news:
- During the GTC keynote, Huang unveiled a $59 Jetson Nano 2GB, a single-board supercomputer geared toward those with an interest in AI and robotics. Nvidia said the developer kit, which includes online tutorials and certification, is designed to "make AI easily accessible for all."
- Nvidia also announced a new partnership with GSK to develop AI-based computational processes for drug discovery and new vaccines. GSK will be able to use the new supercomputer and other AI methods to uncover new clinical and medical data and information.
- Huang and Arm CEO Simon Segars will also hold a keynote chat at tomorrow's digital Arm DevSummit.